Published in Clin Orthop Relat Res on November 01, 1997
SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med (1998) 4.18
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol (1998) 3.10
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene (2001) 2.97
Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci U S A (1994) 2.44
Prosthetic knee replacement after resection of a malignant tumor of the distal part of the femur. Medium to long-term results. J Bone Joint Surg Am (1998) 2.27
Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol (2000) 2.22
MDM2 gene amplification in metastatic osteosarcoma. Cancer Res (1993) 2.15
Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol (1993) 2.01
Osteoid osteoma and osteoblastoma. Current concepts and recent advances. Clin Orthop Relat Res (1986) 1.97
Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. Diagn Mol Pathol (2000) 1.91
Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. J Clin Oncol (1998) 1.81
Acrometastases. A study of twenty-nine patients with osseous involvement of the hands and feet. J Bone Joint Surg Am (1986) 1.68
Nuchal-type fibroma in two related patients with Gardner's syndrome. Am J Surg Pathol (2000) 1.62
Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proc Natl Acad Sci U S A (1992) 1.62
The treatment of aneurysmal bone cyst. Clin Orthop Relat Res (1995) 1.59
Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study. Cancer (1998) 1.56
The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. J Bone Joint Surg Am (1998) 1.56
Cartilage tumors: evaluation and treatment. J Am Acad Orthop Surg (2000) 1.52
Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer Res (1993) 1.50
Prosthetic and extremity survivorship after limb salvage for sarcoma. How long do the reconstructions last? Clin Orthop Relat Res (1993) 1.48
Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements. Clin Cancer Res (2000) 1.46
Prognostic factors for patients with sarcomas of the pelvic bones. Cancer (1998) 1.45
Cardiac arrest during hip arthroplasty with a cemented long-stem component. A report of seven cases. J Bone Joint Surg Am (1991) 1.39
Expression of HER2/erbB-2 correlates with survival in osteosarcoma. J Clin Oncol (1999) 1.39
A rotating-hinge knee replacement for malignant tumors of the femur and tibia. J Arthroplasty (1999) 1.35
Relationship between magnitude of resection, complication, and prosthetic survival after prosthetic knee reconstructions for distal femoral tumors. J Surg Oncol (1999) 1.30
Giant cell tumor of the distal radius. J Hand Surg Am (1995) 1.29
Prognostic impact of P53 status in Ewing sarcoma. Cancer (2000) 1.27
Allograft reconstruction after proximal tibial resection for bone tumors. An analysis of function and outcome comparing allograft and prosthetic reconstructions. Clin Orthop Relat Res (1994) 1.27
Functional and oncological outcome of acetabular reconstruction for the treatment of metastatic disease. J Bone Joint Surg Am (2000) 1.26
Osteosarcoma of the pelvis. Oncologic results of 40 patients. Clin Orthop Relat Res (1998) 1.24
Fibroblast activation protein: purification, epitope mapping and induction by growth factors. Int J Cancer (1994) 1.24
Treatment of soft-tissue sarcomas of the hand. J Bone Joint Surg Am (1995) 1.23
Single-stage posterolateral transpedicle approach for spondylectomy, epidural decompression, and circumferential fusion of spinal metastases. Spine (Phila Pa 1976) (2000) 1.22
Mechanisms of methotrexate resistance in osteosarcoma. Clin Cancer Res (1999) 1.22
Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas. J Mol Diagn (2000) 1.21
A comparison of staging systems for localized extremity soft tissue sarcoma. Cancer (2000) 1.17
The effect of chemotherapy on growth in the skeletally immature individual. Clin Orthop Relat Res (1991) 1.15
Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. Cancer Res (1999) 1.13
Stress fracture MRI. Orthopedics (1993) 1.12
Conservative surgery for giant cell tumors of the sacrum. The role of cryosurgery as a supplement to curettage and partial excision. Cancer (1994) 1.11
Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults. J Clin Oncol (1995) 1.10
Prognostic impact of INK4A deletion in Ewing sarcoma. Cancer (2000) 1.08
Comparative frequency of bone sarcomas among different racial groups. Chin Med J (Engl) (1999) 1.07
Chondrosarcoma. Clin Orthop Relat Res (1986) 1.07
Deep venous thrombosis after orthopedic surgery in adult cancer patients. J Surg Oncol (1998) 1.06
Chemotherapy and P-glycoprotein expression in chondrosarcoma. J Orthop Res (1998) 1.05
EWS rearrangement in Ewing's sarcoma and peripheral neuroectodermal tumor. Molecular detection and correlation with cytogenetic analysis and MIC2 expression. Diagn Mol Pathol (1993) 1.05
Interrelationships of clinical outcome, length of resection, and energy cost of walking after prosthetic knee replacement following resection of a malignant tumor of the distal aspect of the femur. J Bone Joint Surg Am (1998) 1.04
CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons. Int J Cancer (1999) 1.04
The Van Nes tibial rotationplasty. A functionally viable reconstructive procedure in children who have a tumor of the distal end of the femur. J Bone Joint Surg Am (1990) 1.03
Pathologic femoral fracture after periosteal excision and radiation for the treatment of soft tissue sarcoma. Cancer (1998) 1.03
Benign giant-cell tumor of bone with metastasis to mediastinal lymph nodes. A case report of resection facilitated with use of steroids. J Bone Joint Surg Am (1996) 1.02
Osteoarthrosis and congenital dysplasia of the hip in family members of children who have congenital dysplasia of the hip. J Bone Joint Surg Am (1990) 1.01
Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas. Cancer (1994) 1.00
A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas. Breast Cancer Res Treat (2000) 0.99
Sporadic amplification of the MYC gene in human osteosarcomas. Diagn Mol Pathol (1993) 0.98
Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma. Am J Pathol (1997) 0.98
Painful synovitis secondary to gout in the area of a prosthetic hip joint. A case report. J Bone Joint Surg Am (1984) 0.98
Prosthetic arthroplasty of the knee after resection of a sarcoma in the proximal end of the tibia. A report of sixteen cases. J Bone Joint Surg Am (1991) 0.96
Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma. Br J Dermatol (2006) 0.96
MDM2 and CDK4 gene amplification in Ewing's sarcoma. J Pathol (1995) 0.96
Expression of bone morphogenetic proteins and receptors in sarcomas. Clin Orthop Relat Res (1999) 0.95
A custom distal femoral prosthesis for reconstruction of large defects following wide excision for sarcoma: results and prognostic factors. Orthopedics (1995) 0.94
The coexistence and characteristics of osteoarthritis and osteoporosis. J Bone Joint Surg Am (1985) 0.93
MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study. J Clin Oncol (2000) 0.93
Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection. J Thorac Cardiovasc Surg (2000) 0.92
Human epidermal growth factor receptor 2 as a prognostic indicator in osteogenic sarcoma. Clin Orthop Relat Res (2001) 0.91
p53 mutations in chondrosarcoma. Diagn Mol Pathol (1998) 0.91
Treatment of femoral fractures after irradiation. Clin Orthop Relat Res (1998) 0.91
Intralesional resection of primary and metastatic sarcoma involving the spine: outcome analysis of 59 patients. Neurosurgery (2001) 0.89
Algorithm for the surgical treatment of malignant lesions of the proximal tibia. Clin Orthop Relat Res (1999) 0.89
Creatine kinase MB in skeletal muscle and serum of spine-fusion patients. Clin Orthop Relat Res (1985) 0.89
Factors predictive of mortality in pediatric extremity rhabdomyosarcoma. J Pediatr Surg (1990) 0.87
31P NMR spectra of extremity sarcomas: diversity of metabolic profiles and changes in response to chemotherapy. Magn Reson Med (1990) 0.87
Clinical reproducibility of dual energy x-ray absorptiometry. J Orthop Res (1995) 0.87
Structural scoliosis in osteoporotic women. Clin Orthop Relat Res (1985) 0.87
Amputation for recurrent soft tissue sarcoma of the extremity: indications and outcome. Ann Surg Oncol (2001) 0.86
Expression of CD34 in sclerotic ("plywood") fibromas. Am J Dermatopathol (2000) 0.86
Fibrous dysplasia of the second cervical vertebra. A case report. J Bone Joint Surg Am (1990) 0.85
Multiple giant cell tumors and Paget disease of bone: radiographic and clinical correlations. Radiology (1991) 0.84
Soft-tissue sarcoma involving bone or neurovascular structures: MR imaging prognostic factors. Radiology (1997) 0.84
The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas. Eur J Nucl Med (1994) 0.84
Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone. Sarcoma (1997) 0.84
Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma. Am J Surg Pathol (1999) 0.84
Subacute osteomyelitis presenting as bone tumors. Orthopedics (1989) 0.83
Massive solitary tophus containing calcium pyrophosphate dihydrate crystals at the acromioclavicular joint. Clin Orthop Relat Res (1988) 0.83
Effect of low-dose radiation therapy when combined with surgical resection for Ewing sarcoma. Med Pediatr Oncol (1999) 0.83
Computed tomographic evaluation of fatty neoplasms of the extremities. A clinical, radiographic, and histologic review of cases. Orthopedics (1989) 0.83
Primary chondroid melanoma. J Cutan Pathol (2001) 0.83
"Artificial lymphatic system": a new approach to reduce interstitial hypertension and increase blood flow, pH and pO2 in solid tumors. Ann Biomed Eng (2000) 0.82
Quantitation of intraepidermal T-cell subsets in formalin-fixed, paraffin-embedded tissue helps in the diagnosis of mycosis fungoides. J Cutan Pathol (1999) 0.82
Modification of the skin incision for the Van Nes limb rotationplasty. Clin Orthop Relat Res (1987) 0.82
Peak skeletal mass assessment in young adults with idiopathic scoliosis. Spine (Phila Pa 1976) (1989) 0.81
Interstitial fluid pressure and blood flow in canine osteosarcoma and other tumors. Clin Orthop Relat Res (2001) 0.81
Treatment of femoral Ewing's sarcoma. Cancer (1996) 0.81
Gait characteristics of patients after proximal femoral replacement for malignant bone tumour. J Bone Joint Surg Br (2000) 0.81
Osteogenic sarcoma arising in the area of a total hip replacement. A case report. J Bone Joint Surg Am (1990) 0.80
Resection of the sciatic, peroneal, or tibial nerves: assessment of functional status. Ann Surg Oncol (2002) 0.80
Peripheral primitive neuroectodermal tumors in adults: documentation by molecular analysis. J Clin Oncol (1998) 0.79